CSL will pay Alentis $355 million upfront to co-develop lixudebart for rare kidney and liver diseases, with up to $1.2 ...
In an infusion bay at UPMC Children’s Hospital of Pittsburgh, Billy Ellsworth twists the plastic top off of a bottle of Gatorade. “That was kind of tough, to be honest,” he said. “I wasn’t sure I was ...
AnnJi's Rare Disease Drug Clears FDA Hurdle; Stock Surges to NT$86, Setting New Emerging Market High
Taiwan-listed emerging biotech AnnJi (7754.TW) announced that its lead drug candidate AJ201 has received clearance from the U.S. Food and ...
The number of treatments for rare genetic disorders is expected to increase sharply in the next several years.
The family of a 13-year-old boy from Long Beach is asking for help as he remains hospitalized with a rare disease linked to ...
Investing.com-- CSL Ltd (ASX:CSL) shares rose on Monday after the Australian healthcare company said it had agreed to pay up to $1.6 billion to jointly develop and commercialise an experimental ...
CSL (ASX:CSL) has ramped up its research and development efforts via a US$355 million ($515m)-plus drug development collab ...
Alentis to receive US$355 million initial payment and up to US$1.2 billion in commercial milestones, with global profits shared ...
Crohn's disease is surging in America, with a 22 percent increase in just under a decade, particularly in young people.
Australia's CSL said on Monday it had entered into an agreement with Swiss drugmaker Alentis Therapeutics to co-develop and co-promote a treatment for rare kidney and liver diseases, in a deal worth ...
Lito Sousa, the aviation YouTuber known for Aviões e Música, died at 59 after a diagnosis of Creutzfeldt-Jakob disease in August.
Legoland Communications Director Julie Estrada and Master Lego Builder Jose de Paz stopped by the KTLA Weekend Morning News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results